386 related articles for article (PubMed ID: 27737864)
1. Von Willebrand Factor, ADAMTS13, and the Risk of Mortality: The Rotterdam Study.
Sonneveld MA; Franco OH; Ikram MA; Hofman A; Kavousi M; de Maat MP; Leebeek FW
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2446-2451. PubMed ID: 27737864
[TBL] [Abstract][Full Text] [Related]
2. Von Willebrand factor, ADAMTS13 and mortality in dialysis patients.
Ocak G; Roest M; Verhaar MC; Rookmaaker MB; Blankestijn PJ; Bos WJW; Fijnheer R; Péquériaux NC; Dekker FW
BMC Nephrol; 2021 Jun; 22(1):222. PubMed ID: 34134634
[TBL] [Abstract][Full Text] [Related]
3. Association of the von Willebrand Factor-ADAMTS13 Ratio With Incident Cardiovascular Events in Patients With Peripheral Arterial Disease.
Green D; Tian L; Greenland P; Liu K; Kibbe M; Tracy R; Shah S; Wilkins JT; Huffman MD; Liao Y; Lloyd Jones D; McDermott MM
Clin Appl Thromb Hemost; 2017 Oct; 23(7):807-813. PubMed ID: 27317583
[TBL] [Abstract][Full Text] [Related]
4. von Willebrand Factor, ADAMTS13 Activity, and Decline in Kidney Function: A Population-Based Cohort Study.
Sedaghat S; de Vries PS; Boender J; Sonneveld MA; Hoorn EJ; Hofman A; de Maat MP; Franco OH; Ikram MA; Leebeek FW; Dehghan A
Am J Kidney Dis; 2016 Nov; 68(5):726-732. PubMed ID: 27497525
[TBL] [Abstract][Full Text] [Related]
5. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
[TBL] [Abstract][Full Text] [Related]
6. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
[TBL] [Abstract][Full Text] [Related]
7. Von Willebrand factor collagen-binding capacity predicts in-hospital mortality in COVID-19 patients: insight from VWF/ADAMTS13 ratio imbalance.
Philippe A; Gendron N; Bory O; Beauvais A; Mirault T; Planquette B; Sanchez O; Diehl JL; Chocron R; Smadja DM
Angiogenesis; 2021 Aug; 24(3):407-411. PubMed ID: 33974165
[TBL] [Abstract][Full Text] [Related]
8. Platelet Count, ADAMTS13 Activity, von Willebrand Factor Level and Survival in Patients with Colorectal Cancer: 5-Year Follow-up Study.
Garam N; Maláti É; Sinkovits G; Gombos T; Szederjesi A; Barabás L; Gráf L; Kocsis J; Prohászka Z
Thromb Haemost; 2018 Jan; 118(1):123-131. PubMed ID: 29304532
[TBL] [Abstract][Full Text] [Related]
9. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke.
Sonneveld MA; de Maat MP; Portegies ML; Kavousi M; Hofman A; Turecek PL; Rottensteiner H; Scheiflinger F; Koudstaal PJ; Ikram MA; Leebeek FW
Blood; 2015 Dec; 126(25):2739-46. PubMed ID: 26511134
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Function and Cardiovascular Disease: The Mediating Role of Coagulation Factors.
Bano A; Chaker L; de Maat MPM; Atiq F; Kavousi M; Franco OH; Mattace-Raso FUS; Leebeek FWG; Peeters RP
J Clin Endocrinol Metab; 2019 Aug; 104(8):3203-3212. PubMed ID: 30938758
[TBL] [Abstract][Full Text] [Related]
11. Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study.
Sonneveld MA; Kavousi M; Ikram MA; Hofman A; Rueda Ochoa OL; Turecek PL; Franco OH; Leebeek FW; de Maat MP
J Thromb Haemost; 2016 Nov; 14(11):2114-2120. PubMed ID: 27559008
[TBL] [Abstract][Full Text] [Related]
12. Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates.
Strauss T; Elisha N; Ravid B; Rosenberg N; Lubetsky A; Levy-Mendelovich S; Morag I; Nowak Göttl U; Kenet G
Blood Cells Mol Dis; 2017 Sep; 67():14-17. PubMed ID: 28087247
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the Diagnostic Value of Plasma Levels, Activities, and Their Ratios of von Willebrand Factor and ADAMTS13 in Patients with Cerebral Infarction.
Qu L; Jiang M; Qiu W; Lu S; Zhao Y; Xia L; Ruan C; Zhao Y
Clin Appl Thromb Hemost; 2016 Apr; 22(3):252-9. PubMed ID: 25916953
[TBL] [Abstract][Full Text] [Related]
14. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
Akyol O; Akyol S; Chen CH
Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma von Willebrand factor-cleaving protease (ADAMTS13) antigen levels in patients with coronary artery disease.
Miura M; Kaikita K; Matsukawa M; Soejima K; Fuchigami S; Miyazaki Y; Ono T; Uemura T; Tsujita K; Hokimoto S; Sumida H; Sugiyama S; Matsui K; Yamabe H; Ogawa H
Thromb Haemost; 2010 Mar; 103(3):623-9. PubMed ID: 20135067
[TBL] [Abstract][Full Text] [Related]
16. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in von Willebrand factor-cleaving protease (ADAMTS13) and prognosis after acute myocardial infarction.
Matsukawa M; Kaikita K; Soejima K; Fuchigami S; Nakamura Y; Honda T; Tsujita K; Nagayoshi Y; Kojima S; Shimomura H; Sugiyama S; Fujimoto K; Yoshimura M; Nakagaki T; Ogawa H
Am J Cardiol; 2007 Sep; 100(5):758-63. PubMed ID: 17719316
[TBL] [Abstract][Full Text] [Related]
18. ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study.
de Vries PS; van Herpt TT; Ligthart S; Hofman A; Ikram MA; van Hoek M; Sijbrands EJ; Franco OH; de Maat MP; Leebeek FW; Dehghan A
Diabetologia; 2017 Feb; 60(2):280-286. PubMed ID: 27787621
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor and ADAMTS13 plasma in older patients with high CHA2DS2-VASc Score with and without atrial fibrillation.
Zhang F; Yang XC; Jia XW; Tang XH; Wang Z; Wang ZQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4907-4912. PubMed ID: 29164570
[TBL] [Abstract][Full Text] [Related]
20. Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
Siller-Matula J; Lang IM; Schoergenhofer C; Roest M; Jilma B
Thromb Haemost; 2017 Aug; 117(9):1730-1738. PubMed ID: 28726980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
